---
title: "600511.SH (600511.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600511.SH/news.md"
symbol: "600511.SH"
name: "600511.SH"
parent: "https://longbridge.com/en/quote/600511.SH.md"
datetime: "2026-05-20T18:26:56.386Z"
locales:
  - [en](https://longbridge.com/en/quote/600511.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600511.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600511.SH/news.md)
---

# 600511.SH (600511.SH) — Related News

### [Director of the National Tobacco Monopoly Administration, Yao Laiying, meets with Bai Zhongquan, Secretary of the Party Committee and Chairman of Sinopharm Group](https://longbridge.com/en/news/285486641.md)
*2026-05-07T05:06:18.000Z*
> On May 7th, Yao Laiying, Secretary of the Party Leadership Group and Director of the National Tobacco Monopoly Administr

### ["Foreign Capital Highlights" has lowered the target price of SINOPHARM to 22.6 yuan, reducing the earnings forecast for the next three years by 1%](https://longbridge.com/en/news/284297869.md)
*2026-04-28T02:24:00.000Z*
> Citi has lowered the target price for Sinopharm to 22.6 yuan, a decrease of 0.9%, while maintaining a "Buy" rating. The 

### [The Hang Seng Index closed down 52 points and has not yet stabilized at 26,000 points, while the Tech Index rose by about 0.8%](https://longbridge.com/en/news/284178301.md)
*2026-04-27T08:40:39.000Z*
> The Hang Seng Index closed at 25,925 points, down 52 points, failing to stabilize above 26,000 points, with a turnover e

### ["Fight Again Tomorrow" The United States announced the University of Michigan Consumer Confidence Index, Shenhua and Sinopharm announced their performance results](https://longbridge.com/en/news/283818283.md)
*2026-04-23T11:00:00.000Z*
> The United States will announce the University of Michigan Consumer Sentiment Index on Friday, which is expected to drop

### [SINOPHARM: SINOPHARM Medical Devices' operating profit in the first quarter was 220 million yuan, a year-on-year decrease of 20.41%](https://longbridge.com/en/news/283796823.md)
*2026-04-23T09:12:22.000Z*
> SINOPHARM released the financial data of its subsidiary China Medical Devices Co., Ltd. for the period ending March 31, 

### [Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakens](https://longbridge.com/en/news/283669573.md)
*2026-04-22T12:45:28.000Z*
> Sinopharm Group's subsidiary, China National Medicines Corporation, reported a 6.63% increase in Q1 revenue to RMB 13.56

### [Sinopharm Holdings: In the first quarter, Sinopharm's net profit attributable to shareholders was 474 million yuan, a year-on-year increase of 3.32%](https://longbridge.com/en/news/283664021.md)
*2026-04-22T12:21:09.000Z*
> Sinopharm Holdings released the first quarter performance of SINOPHARM(CNCM LTD) for 2026, with operating revenue of 13.

### [SINOPHARM's subsidiary Sinopharm Accord reported a profit of nearly 300 million RMB in the first quarter, down 12%, with revenue declining by 3%](https://longbridge.com/en/news/283576244.md)
*2026-04-22T00:48:00.000Z*
> SINOPHARM announced that its subsidiary Sinopharm Accord Pharmaceuticals reported a first-quarter performance as of Marc